Sponsor or institution
Clinical trials and research at Eydis Bio, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New oral TAK1 inhibitor to help with chemotherapy-related nerve pain
A new oral drug candidate aims to prevent or lessen nerve damage and pain caused by certain chemotherapy treatments in cancer patients.
-
New medicines for lung scarring in scleroderma
This project is developing a new medicine to help people with lung scarring caused by scleroderma, a condition called SSc-ILD.
-
Developing new small molecules to treat Alzheimer's disease
This study is looking for new ways to help people with Alzheimer's by testing special tiny molecules that can reach the brain and target a protein called TAK1, which is linked to memory loss and brain cell damage, with the hope of finding better treatments to improve thinking skills and overall well-being.
-
New treatments for lung disease related to systemic sclerosis
This study is testing a new treatment for people with systemic sclerosis-related lung disease, aiming to help reduce lung inflammation and scarring by targeting a specific protein, and it has shown promising results in early tests.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.